TCGX Acquisition Corp. (TCGX)

$10.75 +0.45 (4.37%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,021,656
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

TCGX Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.

Industry: Shell Companies
Sector: Financial Services
Phone: 650 924 9424
Address:
245 Lytton Ave., Suite 350, Palo Alto, United States
juhbubba
juhbubba Aug. 7 at 3:48 PM
$TCGX here we go
0 · Reply
KY3000
KY3000 Aug. 7 at 3:31 PM
$LEGN $TCGX wtf is going on
0 · Reply
Biotechsamy
Biotechsamy Aug. 7 at 1:53 PM
$LEGN Ex-CEO Ying Huang, Ph.D was appointed as the Director of TCGX. $TCGX, newly formed Special Purpose Acquisition Company (SPAC)., officially began trading on the Nasdaq Capital Market under the ticker NASDAQ: TCGX on August 5, 2026. This SPAC intends to focus its search for business acquisition targets within the life sciences. Unlike many standard SPACs, investors in TCGX's offering do not receive warrants exercisable following the completion of an initial business combination. A "warrantless" or stock-only SPAC is rare. It generally indicates that the sponsor (TCG Crossover) believes their reputation, track record, and deal-sourcing pipeline are strong enough to attract institutional capital without needing to offer derivative sweeteners. Furthermore, this structure is highly favorable for the eventual acquisition target, as it eliminates the massive future share dilution that typically plagues companies when early SPAC investors later exercise their warrants.
1 · Reply
Latest News on TCGX
TCGX Acquisition opens at $10.30, IPO priced at $10 per share

2026-08-05T18:05:58.000Z - 5 weeks ago

TCGX Acquisition opens at $10.30, IPO priced at $10 per share

TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering

Aug 4, 2026, 5:10 PM EDT - 6 weeks ago

TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering

TCGX Acquisition IPO Registration Document (S-1)

Jul 20, 2026, 4:20 PM EDT - 1 month ago

TCGX Acquisition IPO Registration Document (S-1)

juhbubba
juhbubba Aug. 7 at 3:48 PM
$TCGX here we go
0 · Reply
KY3000
KY3000 Aug. 7 at 3:31 PM
$LEGN $TCGX wtf is going on
0 · Reply
Biotechsamy
Biotechsamy Aug. 7 at 1:53 PM
$LEGN Ex-CEO Ying Huang, Ph.D was appointed as the Director of TCGX. $TCGX, newly formed Special Purpose Acquisition Company (SPAC)., officially began trading on the Nasdaq Capital Market under the ticker NASDAQ: TCGX on August 5, 2026. This SPAC intends to focus its search for business acquisition targets within the life sciences. Unlike many standard SPACs, investors in TCGX's offering do not receive warrants exercisable following the completion of an initial business combination. A "warrantless" or stock-only SPAC is rare. It generally indicates that the sponsor (TCG Crossover) believes their reputation, track record, and deal-sourcing pipeline are strong enough to attract institutional capital without needing to offer derivative sweeteners. Furthermore, this structure is highly favorable for the eventual acquisition target, as it eliminates the massive future share dilution that typically plagues companies when early SPAC investors later exercise their warrants.
1 · Reply